Strong Momentum Meets Stretched Valuations as Yatharth Hospital & Trauma Care Services Ltd Reaches All-Time High

1 hour ago
share
Share Via
Yatharth Hospital & Trauma Care Services Ltd has reached a significant milestone by touching an all-time high price of Rs. 887 on 11 May 2026, marking a remarkable phase in the company’s market performance and reflecting sustained investor confidence in the hospital sector.
Strong Momentum Meets Stretched Valuations as Yatharth Hospital & Trauma Care Services Ltd Reaches All-Time High

Stock Performance and Market Context

The stock’s new peak at Rs. 887 represents a 2.83% intraday rise and a 0.93% gain on the day, outperforming the broader Sensex which declined by 1.17%. This marks the fourth consecutive day of gains, during which the stock has appreciated by 7.91%, underscoring a strong upward momentum. Over the past week, the stock has risen 5.86%, while the Sensex has fallen 1.10%. The one-month performance is even more striking, with a 15.29% increase compared to the Sensex’s 1.46% decline.

Over a three-month horizon, Yatharth Hospital & Trauma Care Services Ltd has surged 27.10%, contrasting sharply with the Sensex’s 9.28% drop. The stock’s one-year return stands at an impressive 87.32%, significantly outpacing the Sensex’s negative 3.82% performance. Year-to-date, the stock has gained 27.75%, while the Sensex has declined 10.33%. These figures highlight the company’s resilience and strong market positioning within the hospital sector.

Technical Indicators and Trend Analysis

The technical outlook for Yatharth Hospital & Trauma Care Services Ltd is predominantly bullish. The current trend, which shifted to bullish on 8 May 2026 at a price of Rs. 862.60, is supported by multiple indicators. Weekly MACD readings are bullish, and Bollinger Bands signal strength on both weekly and monthly timeframes. Moving averages across 5-day, 20-day, 50-day, 100-day, and 200-day periods confirm the stock is trading above key support levels, reinforcing the positive momentum.

Immediate support is identified at the 52-week low of Rs. 476.55, while resistance levels were previously noted at Rs. 776.91 (20-day moving average), Rs. 683.78 (100-day moving average), and Rs. 713.42 (200-day moving average). The recent breakthrough past these resistance points culminated in the new all-time high of Rs. 887, signalling a robust technical foundation for the stock’s current valuation.

Valuation Metrics

As of 11 May 2026, the stock is priced at Rs. 870.65, reflecting a price-to-earnings (P/E) ratio of 50 times on a trailing twelve months (TTM) basis. The price-to-book value (P/BV) stands at 4.92 times, while enterprise value multiples include EV/EBITDA at 30.95 times and EV/EBIT at 42.49 times. The EV/Sales multiple is 7.39 times, and EV/Capital Employed is 5.60 times. The PEG ratio is 1.74, indicating the stock’s valuation relative to its earnings growth rate.

Dividend metrics are not applicable as the company has not declared dividends recently, with no dividend yield, payout, or ex-dividend dates recorded.

Quality and Financial Strength

Yatharth Hospital & Trauma Care Services Ltd is classified as an average quality company based on long-term financial performance. Key quality factors include a 5-year sales compound annual growth rate (CAGR) of 30.84% and a 5-year EBIT growth of 15.55%. The company maintains an excellent capital structure with negligible debt, reflected in an average debt to EBITDA ratio of 0.23 and a net cash position indicated by a negative net debt to equity ratio of -0.15.

Interest coverage is strong at 36.66 times EBIT to interest, underscoring the company’s ability to service debt comfortably. Return on capital employed (ROCE) averages 19.03%, which is considered good, while return on equity (ROE) is weaker at 11.44%. Institutional holdings are moderate at 17.26%, and pledged shares constitute 10.73% of the total.

Recent Financial Trends

The company’s short-term financial trend as of December 2025 is positive. Quarterly net sales reached a high of ₹320.47 crores, with profit before depreciation, interest, and taxes (Pbdit) at ₹74.25 crores and profit after tax (PAT) at ₹45.35 crores. Earnings per share (EPS) for the quarter stood at ₹4.71, marking the highest recorded levels.

Some operational ratios such as inventory turnover and debtors turnover were at their lowest levels in the half-year period, with inventory turnover at 34.00 times and debtors turnover at 2.92 times, indicating areas for efficiency improvement.

Delivery Volumes and Market Capitalisation

Delivery volumes have shown a notable increase, with a 41.7% rise over the past month and a 16.04% increase on the latest trading day compared to the 5-day average. On 7 May 2026, delivery volume reached 3.47 lakh shares, representing 37.43% of total volume, higher than the trailing one-month average of 2.47 lakh shares and previous month’s 1.74 lakh shares.

The company is classified as a small-cap stock, reflecting its market capitalisation grade. The Mojo Score assigned by MarketsMOJO is 65.0, with a current Mojo Grade of Hold, upgraded from Sell on 10 April 2026, indicating an improved assessment of the company’s fundamentals and market position.

Summary

Yatharth Hospital & Trauma Care Services Ltd’s achievement of an all-time high price of Rs. 887 on 11 May 2026 is a testament to its sustained growth, strong financial health, and positive market sentiment. The stock’s consistent outperformance relative to the Sensex and hospital sector benchmarks, combined with bullish technical indicators and solid quality metrics, highlight the company’s robust standing in the healthcare industry.

While valuation multiples suggest a premium pricing, the company’s strong sales growth, excellent capital structure, and positive short-term financial trends provide context for this elevated valuation. The recent upgrade in Mojo Grade to Hold by MarketsMOJO further reflects the evolving confidence in the stock’s performance trajectory.

Overall, Yatharth Hospital & Trauma Care Services Ltd’s milestone of reaching a new peak price marks a significant chapter in its market journey, underscoring its position as a noteworthy player in the hospital sector.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News